Sunstone increases share in Swedish biotech company

The Swedish biotech company Cantagia issues new shares for SEK 232 million (USD 27.71 million) and the major investor Sunstone Capital takes the opportunity to increase its investments in the company that aims for going public on Nasdaq Stockholm in 2018.

Partner i Sunstone Capital

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Omstridt parallelimportør går konkurs

Parallelimportøren Europharma, der to gange i 2017 blev suspenderet af Lægemiddelstyrelsen, er gået konkurs. Selskabet har erkendt, at et varelager for 50 mio. kr. er usælgeligt.

Related articles